Target Price | CHF4,162.10 |
Price | CHF4,090.00 |
Potential | 1.76% |
Number of Estimates | 21 |
21 Analysts have issued a price target Givaudan 2026 . The average Givaudan target price is CHF4,162.10. This is 1.76% higher than the current stock price. The highest price target is CHF4,900.00 19.80% , the lowest is CHF3,500.00 14.43% . | |
A rating was issued by 23 analysts: 8 Analysts recommend Givaudan to buy, 10 to hold and 5 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Givaudan stock has an average upside potential 2026 of 1.76% . Most analysts recommend the Givaudan stock at Hold. |
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CHF | 7.41 | 7.68 |
7.19% | 3.68% | |
EBITDA Margin | 23.87% | 24.28% |
12.12% | 1.73% | |
Net Margin | 14.72% | 14.88% |
13.88% | 1.12% |
20 Analysts have issued a sales forecast Givaudan 2025 . The average Givaudan sales estimate is CHF7.7b . This is 3.68% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF7.8b 5.69% , the lowest is CHF7.5b 1.38% .
This results in the following potential growth metrics:
2024 | CHF7.4b | 7.19% |
---|---|---|
2025 | CHF7.7b | 3.68% |
2026 | CHF8.0b | 4.50% |
2027 | CHF8.4b | 5.12% |
2028 | CHF9.0b | 6.79% |
2029 | CHF9.7b | 7.73% |
19 Analysts have issued an Givaudan EBITDA forecast 2025. The average Givaudan EBITDA estimate is CHF1.9b . This is 5.47% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF1.9b 8.99% , the lowest is CHF1.8b 0.45% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | CHF1.8b | 20.18% |
---|---|---|
2025 | CHF1.9b | 5.47% |
2026 | CHF2.0b | 4.56% |
2027 | CHF2.1b | 5.33% |
2028 | CHF2.1b | 3.54% |
2029 | CHF2.2b | 2.39% |
2024 | 23.87% | 12.12% |
---|---|---|
2025 | 24.28% | 1.73% |
2026 | 24.29% | 0.04% |
2027 | 24.34% | 0.21% |
2028 | 23.60% | 3.04% |
2029 | 22.43% | 4.96% |
14 Givaudan Analysts have issued a net profit forecast 2025. The average Givaudan net profit estimate is CHF1.1b . This is 4.86% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.2b 9.40% , the lowest is CHF1.1b 1.82% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF1.1b | 22.06% |
---|---|---|
2025 | CHF1.1b | 4.86% |
2026 | CHF1.2b | 8.26% |
2027 | CHF1.3b | 7.81% |
2028 | CHF1.4b | 2.92% |
2029 | CHF1.4b | 1.35% |
2024 | 14.72% | 13.88% |
---|---|---|
2025 | 14.88% | 1.12% |
2026 | 15.42% | 3.63% |
2027 | 15.81% | 2.53% |
2028 | 15.24% | 3.61% |
2029 | 14.34% | 5.91% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | 118.17 | 123.91 |
22.06% | 4.86% | |
P/E | 33.01 | |
EV/Sales | 5.43 |
14 Analysts have issued a Givaudan forecast for earnings per share. The average Givaudan EPS is CHF123.91 . This is 4.86% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF129.28 9.40% , the lowest is CHF116.02 1.82% .
This results in the following potential growth metrics and future valuations:
2024 | CHF118.17 | 22.06% |
---|---|---|
2025 | CHF123.91 | 4.86% |
2026 | CHF134.15 | 8.26% |
2027 | CHF144.63 | 7.81% |
2028 | CHF148.85 | 2.92% |
2029 | CHF150.87 | 1.36% |
Current | 34.61 | 17.34% |
---|---|---|
2025 | 33.01 | 4.62% |
2026 | 30.49 | 7.63% |
2027 | 28.28 | 7.25% |
2028 | 27.48 | 2.83% |
2029 | 27.11 | 1.35% |
Based on analysts' sales estimates for 2025, the Givaudan stock is valued at an EV/Sales of 5.43 and an P/S ratio of 4.91 .
This results in the following potential growth metrics and future valuations:
Current | 5.63 | 6.63% |
---|---|---|
2025 | 5.43 | 3.56% |
2026 | 5.20 | 4.31% |
2027 | 4.94 | 4.87% |
2028 | 4.63 | 6.36% |
2029 | 4.30 | 7.17% |
Current | 5.09 | 5.86% |
---|---|---|
2025 | 4.91 | 3.55% |
2026 | 4.70 | 4.31% |
2027 | 4.47 | 4.87% |
2028 | 4.19 | 6.36% |
2029 | 3.89 | 7.18% |
Analyst | Rating | Action | Date |
---|---|---|---|
RESEARCH PARTNERS AG |
Buy
➜
Buy
|
Unchanged | Apr 02 2025 |
BERENBERG |
Hold
➜
Buy
|
Upgrade | Mar 31 2025 |
ESN/CIC MARKET SOLUTIONS |
Neutral
➜
Neutral
|
Unchanged | Mar 30 2025 |
BAADER HELVEA EQUITY RESEARCH |
Buy
➜
Buy
|
Unchanged | Mar 25 2025 |
REDBURN ATLANTIC |
Neutral
➜
Neutral
|
Unchanged | Mar 21 2025 |
STIFEL EUROPE |
Hold
➜
Hold
|
Unchanged | Mar 20 2025 |
JEFFERIES |
Underperform
➜
Underperform
|
Unchanged | Mar 12 2025 |
Analyst Rating | Date |
---|---|
Unchanged
RESEARCH PARTNERS AG:
Buy
➜
Buy
|
Apr 02 2025 |
Upgrade
BERENBERG:
Hold
➜
Buy
|
Mar 31 2025 |
Unchanged
ESN/CIC MARKET SOLUTIONS:
Neutral
➜
Neutral
|
Mar 30 2025 |
Unchanged
BAADER HELVEA EQUITY RESEARCH:
Buy
➜
Buy
|
Mar 25 2025 |
Unchanged
REDBURN ATLANTIC:
Neutral
➜
Neutral
|
Mar 21 2025 |
Unchanged
STIFEL EUROPE:
Hold
➜
Hold
|
Mar 20 2025 |
Unchanged
JEFFERIES:
Underperform
➜
Underperform
|
Mar 12 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.